Literature DB >> 9274717

Coupling of cell-binding ligands to polyethylenimine for targeted gene delivery.

R Kircheis1, A Kichler, G Wallner, M Kursa, M Ogris, T Felzmann, M Buchberger, E Wagner.   

Abstract

Recently the high transfection potential of the cationic polymer polyethylenimine (PEI) was described (Boussif O et al. Proc Natl Acad Sci USA 1995; 92: 7297-7301). To combine the promising DNA delivering activity of PEI with the concept of receptor-mediated gene delivery, cell-binding ligands (transferrin or antiCD3 antibody) were incorporated by covalent linkage to PEI. DNA complexes of PEI or ligand-PEI conjugates were tested for transfection of cultured neuroblastoma Neuro 2A cells, melanoma B16 or H225 cells, erythroid leukemic K562 cells and T cell leukemia Jurkat E6.1 cells. Depending on the cell line, incorporation of the cell-binding ligand resulted in an up to 1000-fold increased transfection efficiency. This activity depends on ligand-receptor interaction and was observed also at low PEI cation:DNA anion ratios where ligand-free PEI lacks efficiency. Depending on the cell-binding ligand, specific targeting (CD3 antibody, Jurkat cells) can be achieved. Gene transfer can be augmented by the addition of an endosome-destabilizing influenza peptide, but is not dependent on the presence of additional endosomolytic agents. Application of transferrin-PEI for the production of murine interleukin-2 in B16 cells resulted in exceptionally high secretion rates of 19 micrograms IL-2 protein per 10(6) cells per 24 h.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9274717     DOI: 10.1038/sj.gt.3300418

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  40 in total

Review 1.  Design of modular non-viral gene therapy vectors.

Authors:  Laura De Laporte; Jennifer Cruz Rea; Lonnie D Shea
Journal:  Biomaterials       Date:  2005-10-21       Impact factor: 12.479

Review 2.  Regulatable gene expression systems for gene therapy applications: progress and future challenges.

Authors:  S Goverdhana; M Puntel; W Xiong; J M Zirger; C Barcia; J F Curtin; E B Soffer; S Mondkar; G D King; J Hu; S A Sciascia; M Candolfi; D S Greengold; P R Lowenstein; M G Castro
Journal:  Mol Ther       Date:  2005-08       Impact factor: 11.454

3.  Topical application of plasmid DNA to mouse and human skin.

Authors:  Nuschin Meykadeh; Alireza Mirmohammadsadegh; Zhijun Wang; Etiena Basner-Tschakarjan; Ulrich R Hengge
Journal:  J Mol Med (Berl)       Date:  2005-05-19       Impact factor: 4.599

Review 4.  Regulatable gene expression systems for gene therapy.

Authors:  Nuria Vilaboa; Richard Voellmy
Journal:  Curr Gene Ther       Date:  2006-08       Impact factor: 4.391

5.  An epidermal growth factor-like repeat of Del1 protein increases the efficiency of gene transfer in vitro.

Authors:  Hisataka Kitano; Chiaki Hidai; Masatoshi Kawana; Shinichiro Kokubun
Journal:  Mol Biotechnol       Date:  2008-03-06       Impact factor: 2.695

6.  Layer-by-layer deposition of oppositely charged polyelectrolytes on the surface of condensed DNA particles.

Authors:  V S Trubetskoy; A Loomis; J E Hagstrom; V G Budker; J A Wolff
Journal:  Nucleic Acids Res       Date:  1999-08-01       Impact factor: 16.971

Review 7.  Targeted polymeric nanoparticles for cancer gene therapy.

Authors:  Jayoung Kim; David R Wilson; Camila G Zamboni; Jordan J Green
Journal:  J Drug Target       Date:  2015-06-10       Impact factor: 5.121

8.  Polyarginine molecular weight determines transfection efficiency of calcium condensed complexes.

Authors:  Nabil A Alhakamy; Cory J Berkland
Journal:  Mol Pharm       Date:  2013-04-15       Impact factor: 4.939

9.  Polyethylenimine-mediated gene delivery to the lung and therapeutic applications.

Authors:  Sante Di Gioia; Massimo Conese
Journal:  Drug Des Devel Ther       Date:  2009-02-06       Impact factor: 4.162

10.  Intratumoral injection of 188Re labeled cationic polyethylenimine conjugates: a preliminary report.

Authors:  Eun-Mi Kim; Hwan-Jeong Jeong; Young-Jun Heo; Hyung-Bae Moon; Hee-Seung Bom; Chang-Guhn Kim
Journal:  J Korean Med Sci       Date:  2004-10       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.